Financial Research
– JPMorgan has downgraded Teva to “Underweight”, just two months after downgrading it to “Neutral.” – JPMorgan has downgraded Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA) to...
Hi, what are you looking for?
– JPMorgan has downgraded Teva to “Underweight”, just two months after downgrading it to “Neutral.” – JPMorgan has downgraded Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA) to...